These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2151869)

  • 1. Ultrastructural and electrophysiological alterations during the development of catecholamine-induced cardiac hypertrophy and failure.
    Mészáros J; Lévai G
    Acta Biol Hung; 1990; 41(4):289-307. PubMed ID: 2151869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the factors influencing cardiac growth. II. Digitoxin treatment and isoproterenol-induced cardiac hypertrophy in the rat.
    Szabó J; Nosztray K; Takács IE; Szegi J
    Acta Biol Hung; 1985; 36(3-4):305-12. PubMed ID: 2436403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
    Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial characteristics of pressure overload hypertrophy. A structural and functional study.
    Breisch EA; White FC; Bloor CM
    Lab Invest; 1984 Sep; 51(3):333-42. PubMed ID: 6236333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine induced cardiac hypertrophy.
    Tang Q; Taylor PB; Helbing RK
    Can J Cardiol; 1987 Sep; 3(6):311-6. PubMed ID: 2962704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomegaly in chronic anemia in ratsman experimental study including ultrastructural, histometric, and stereologic observations.
    Datta BN; Silver MD
    Lab Invest; 1975 Apr; 32(4):503-14. PubMed ID: 123972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental cardiac hypertrophy induced by isoproterenol in the rat.
    Szabó J; Csáky L; Szegi J
    Acta Physiol Acad Sci Hung; 1975; 46(3):281-5. PubMed ID: 143367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Absence, in the hypertrophied rat heart caused by aortocaval fistula, of several metabolic and electrophysiological changes seen in other models of hypertrophy].
    Thollon C; Aussedat J; Verdetti J; Kreher P
    C R Acad Sci III; 1985; 300(16):607-12. PubMed ID: 3158383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamic biochemical, metrometric and histomorphological studies in isoproterenol-induced myocardial hypertrophy and its regression in rats].
    Prodanov K; Kolarova R; Tsakova L; Balutsov M
    Eksp Med Morfol; 1991; 30(1):26-30. PubMed ID: 1832104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial morphological characteristics and proarrhythmic substrate in the rat model of heart failure due to chronic volume overload.
    Benes J; Melenovsky V; Skaroupkova P; Pospisilova J; Petrak J; Cervenka L; Sedmera D
    Anat Rec (Hoboken); 2011 Jan; 294(1):102-11. PubMed ID: 21157921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative ultrastructural aspects of cardiac hypertrophy.
    Tomanek RJ
    Tex Rep Biol Med; 1979; 39():111-22. PubMed ID: 162243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure.
    Hohimer AR; Davis LE; Hatton DC
    Can J Physiol Pharmacol; 2005 Feb; 83(2):191-7. PubMed ID: 15791293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ouabain in catecholamine-induced cardiac hypertrophy.
    Mészáros J; Pásztor B
    Acta Physiol Hung; 1995; 83(1):55-62. PubMed ID: 7660838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphologic findings during regression of heart hypertrophy].
    Frenzel H
    Z Kardiol; 1985; 74 Suppl 7():107-18. PubMed ID: 2936013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in sarcolemmal adenosine triphosphatase activity and in ouabain sensitivity of rat myocardium in isoproterenol-induced cardiac hypertrophy.
    Szabó J; Nosztray K; Szegi J
    Pol J Pharmacol Pharm; 1989; 41(6):553-9. PubMed ID: 2562064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
    Gao JP; Chen CX; Wang Y; Lü J; Gu WL
    J Pharm Pharmacol; 2009 May; 61(5):677-83. PubMed ID: 19406008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy.
    Sakamoto M; Minamino T; Toko H; Kayama Y; Zou Y; Sano M; Takaki E; Aoyagi T; Tojo K; Tajima N; Nakai A; Aburatani H; Komuro I
    Circ Res; 2006 Dec; 99(12):1411-8. PubMed ID: 17095722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
    Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
    Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.
    Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T
    Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats.
    Tsutsui H; Ishibashi Y; Takahashi M; Namba T; Tagawa H; Imanaka-Yoshida K; Takeshita A
    J Mol Cell Cardiol; 1999 Jun; 31(6):1203-13. PubMed ID: 10371695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.